Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiogenesis Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00861419
What this trial is testing

To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.

Who this might be right for
Advanced Solid Tumors
Amgen 88
Not applicableEnded earlyNCT00657098
What this trial is testing

Side Effects of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) Directed Therapy

Who this might be right for
Metastatic Malignancies
University Medical Center Groningen 73
Very early researchStudy completedNCT02806817
What this trial is testing

ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism

Who this might be right for
Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastEarly-Stage Breast Carcinoma
Centro Nacional de Investigaciones Oncologicas CARLOS III 40
Testing effectiveness (Phase 2)UnknownNCT04446091
What this trial is testing

A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)

Who this might be right for
Colorectal Cancer
Zhejiang Cancer Hospital 40
Testing effectiveness (Phase 2)UnknownNCT05549466
What this trial is testing

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 84
Not applicableStudy completedNCT02825420
What this trial is testing

Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients

Who this might be right for
Relapsed Ovarian Cancer
PharmaMar 220
Not applicableStudy completedNCT00892398
What this trial is testing

Trabeculectomy With Mitomycin C Associated With Sub-conjunctival Injection of Ranibizumab

Who this might be right for
Glaucoma
Maisonneuve-Rosemont Hospital 242
Testing effectiveness (Phase 2)Looking for participantsNCT06446154
What this trial is testing

Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaImmune Checkpoint InhibitorsAnti-angiogenic Therapy+1 more
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Looking for participantsNCT07003022
What this trial is testing

Phase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC

Who this might be right for
Colo-rectal CancerMSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
Fudan University 40
Testing effectiveness (Phase 2)Ended earlyNCT00356681
What this trial is testing

AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer

Who this might be right for
Breast NeoplasmsBreast TumorsBreast Cancer+1 more
Amgen 282
Testing effectiveness (Phase 2)Looking for participantsNCT06482801
What this trial is testing

Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT

Who this might be right for
Liver CancerAntibody
Second Affiliated Hospital of Guangzhou Medical University 90
Large-scale testing (Phase 3)Looking for participantsNCT07472140
What this trial is testing

PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancersPrimary Peritoneal Cancer
N.N. Alexandrov National Cancer Centre 120
Testing effectiveness (Phase 2)Study completedNCT02465502
What this trial is testing

Regorafenib in Subjects With Antiangiogenic-naive and Chemotherapy-refractory Advanced Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Bayer 59
Testing effectiveness (Phase 2)UnknownNCT06134193
What this trial is testing

Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer

Who this might be right for
CarcinomaIntrahepatic CholangiocarcinomaGallbladder Cancer+5 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06750848
What this trial is testing

Chidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast Cancer

Who this might be right for
Advanced Breast Cancer
Jundong Wu 48
Testing effectiveness (Phase 2)Study completedNCT01227928
What this trial is testing

Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women

Who this might be right for
Neoplasms, Ovarian
GlaxoSmithKline 145
Large-scale testing (Phase 3)Study completedNCT00327444
What this trial is testing

Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites

Who this might be right for
Ovarian NeoplasmsAscites
Sanofi 58
Not applicableStudy completedNCT00602862
What this trial is testing

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

Who this might be right for
Clear Cell Renal Cell Carcinoma
Radboud University Medical Center 26
Testing effectiveness (Phase 2)Study completedNCT00387751
What this trial is testing

Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage III Skin MelanomaStage IV Skin Melanoma
National Cancer Institute (NCI) 14
Not applicableStudy completedNCT05208931
What this trial is testing

Development of an Optimal Algorithm for the Management of Patients With Retinal Pigment Epithelium Detachment in Neovascular Age-related Macular Degeneration Using Artificial Intelligence

Who this might be right for
Neovascular Age-related Macular Degeneration
The S.N. Fyodorov Eye Microsurgery State Institution 300
Next Page